The Expanding Role of Tumor Necrosis Factor-α Inhibitors in the Management of Rheumatic Diseases
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
1
Page:
479-491
Author(s):
Yasser El Miedany
Preface [Hot Topic: Transcription Factors as Targets of Novel Therapeutic Approaches of Autoimmune Diseases (Executive Editor: Gunther Ne)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
ii-ii
Author(s):
Gunther Neeck
Transcription Factors in Autoimmune Diseases
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2787-2796
Author(s):
Martin Eggert, Andreas Kluter, Uwe K. Zettl and Gunther Neeck
The Use of Nitric Oxide Synthase Inhibitors in Inflammatory Diseases: A Novel Class of Anti-Inflammatory Agents
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
3
Page:
271-301
Author(s):
Bahar Tunctan and Sedat Altug
Antisense Strategies
Journal:
Current Molecular Medicine
Volume:
4
Page:
465-487
Author(s):
Stanley T. Crooke
Epidemiology of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
121-128
Author(s):
Luigi Naldi
The Psoriasis Genetics as a Model of Complex Disease
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
129-136
Author(s):
Emiliano Giardina, Cecilia Sinibaldi and Giuseppe Novelli
Established Treatments of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
145-156
Author(s):
Peter C.M. van de Kerkhof and Wijnand H.P.M. Vissers
Chemokines and Chemokine Receptors as Targets in the Therapy of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
169-174
Author(s):
Bernhard Homey
Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
3
Page:
175-183
Author(s):
Paolo Gisondi, Emanuela Gubinelli, Barbara Cocuroccia and Giampiero Girolomoni